These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24777289)

  • 1. Diversification of ⁹⁹Mo/(99m)Tc Supply.
    Dick D
    J Nucl Med; 2014 Jun; 55(6):875-6. PubMed ID: 24777289
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation of Multi-Curie Production of (99m)Tc by Conventional Medical Cyclotrons.
    Bénard F; Buckley KR; Ruth TJ; Zeisler SK; Klug J; Hanemaayer V; Vuckovic M; Hou X; Celler A; Appiah JP; Valliant J; Kovacs MS; Schaffer P
    J Nucl Med; 2014 Jun; 55(6):1017-22. PubMed ID: 24722529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclotron production of
    Gumiela M
    Nucl Med Biol; 2018 Mar; 58():33-41. PubMed ID: 29331921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversification of 99Mo/99mTc separation: non–fission reactor production of 99Mo as a strategy for enhancing 99mTc availability.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2015 Jan; 56(1):159-61. PubMed ID: 25537991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclotron Production of (99m)Tc using (100)Mo2C targets.
    Richards VN; Mebrahtu E; Lapi SE
    Nucl Med Biol; 2013 Oct; 40(7):939-45. PubMed ID: 23890695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclotron production of (99m)Tc: experimental measurement of the (100)Mo(p,x)(99)Mo, (99m)Tc and (99g)Tc excitation functions from 8 to 18 MeV.
    Gagnon K; Bénard F; Kovacs M; Ruth TJ; Schaffer P; Wilson JS; McQuarrie SA
    Nucl Med Biol; 2011 Aug; 38(6):907-16. PubMed ID: 21843787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of radioactive waste generated during the cyclotron production of
    Stothers LA; Hou X; Vuckovic M; Buckley K; Bénard F; Schaffer P; Celler A
    Phys Med Biol; 2019 Feb; 64(5):055008. PubMed ID: 30669132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust high-yield ~1 TBq production of cyclotron based sodium [
    Andersson JD; Thomas B; Selivanova SV; Berthelette E; Wilson JS; McEwan AJB; Gagnon K
    Nucl Med Biol; 2018 May; 60():63-70. PubMed ID: 29571068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graphical user interface for yield and dose estimations for cyclotron-produced technetium.
    Hou X; Vuckovic M; Buckley K; Bénard F; Schaffer P; Ruth T; Celler A
    Phys Med Biol; 2014 Jul; 59(13):3337-52. PubMed ID: 24874744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversification in the Supply Chain of (99)Mo Ensures a Future for (99m)Tc.
    Cutler CS; Schwarz SW
    J Nucl Med; 2014 Jul; 55(7):1208-13. PubMed ID: 24854794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons.
    Boschi A; Martini P; Pasquali M; Uccelli L
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1402-1412. PubMed ID: 28443689
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
    Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
    Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility studies towards future self-sufficient supply of the (99)Mo-(99m)Tc isotopes with Japanese accelerators.
    Nakai K; Takahashi N; Hatazawa J; Shinohara A; Hayashi Y; Ikeda H; Kanai Y; Watabe T; Fukuda M; Hatanaka K
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(10):413-21. PubMed ID: 25504230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of relationships between irradiation parameters and the reproducibility of cyclotron-produced (99m)Tc yields.
    Tanguay J; Hou X; Buckley K; Schaffer P; Bénard F; Ruth TJ; Celler A
    Phys Med Biol; 2015 May; 60(10):3883-903. PubMed ID: 25909462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix.
    Chakravarty R; Ram R; Dash A; Pillai MR
    Nucl Med Biol; 2012 Oct; 39(7):916-22. PubMed ID: 22632898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals.
    Martini P; Boschi A; Cicoria G; Zagni F; Corazza A; Uccelli L; Pasquali M; Pupillo G; Marengo M; Loriggiola M; Skliarova H; Mou L; Cisternino S; Carturan S; Melendez-Alafort L; Uzunov NM; Bello M; Alvarez CR; Esposito J; Duatti A
    Appl Radiat Isot; 2018 Sep; 139():325-331. PubMed ID: 29936404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained availability of 99mTc: possible paths forward.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2013 Feb; 54(2):313-23. PubMed ID: 23255729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99Mo/(99m)Tc separation: an assessment of technology options.
    Dash A; Knapp FF; Pillai MR
    Nucl Med Biol; 2013 Feb; 40(2):167-76. PubMed ID: 23142410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molybdenum target specifications for cyclotron production of 99mTc based on patient dose estimates.
    Hou X; Tanguay J; Buckley K; Schaffer P; Bénard F; Ruth TJ; Celler A
    Phys Med Biol; 2016 Jan; 61(2):542-53. PubMed ID: 26683410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function.
    Neyt S; Vliegen M; Verreet B; De Lombaerde S; Braeckman K; Vanhove C; Huisman MT; Dumolyn C; Kersemans K; Hulpia F; Van Calenbergh S; Mannens G; De Vos F
    Nucl Med Biol; 2016 Oct; 43(10):642-9. PubMed ID: 27513813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.